DCF — MERCY MEDICAL CENTER MT. SHASTA
Enterprise Value: $-96.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-96.9M
Enterprise Value
$-30.9M
PV of Cash Flows
$-66.0M
PV of Terminal Value
$-106.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $67.4M | $-5.9M | -9.0% | $-8.8M | $-8.0M |
| Year 2 | $69.4M | $-5.4M | -8.0% | $-8.3M | $-6.9M |
| Year 3 | $71.5M | $-4.8M | -7.0% | $-7.9M | $-5.9M |
| Year 4 | $73.6M | $-4.6M | -6.0% | $-7.7M | $-5.3M |
| Year 5 | $75.8M | $-4.6M | -6.0% | $-7.8M | $-4.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-96.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$65.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09272611902112836
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5